Table 1 Patient demographics, disease, and treatment characteristics
Total | ||
|---|---|---|
n = 21 | (%) | |
Age (years) | ||
Median | 58 | |
Range | 30–75 | |
Time to Failure (months) | ||
Median | 12 | |
Range | 5–69 | |
Sex | ||
Male | 18 | (86) |
Female | 3 | (14) |
Origin | ||
Nasopharynx | 6 | (28) |
Oropharynx | 5 | (24) |
Hypopharynx | 5 | (24) |
Unknown primary | 5 | (24) |
T-category | ||
T0 | 5 | (24) |
T1 | 1 | (5) |
T2 | 7 | (33) |
T3 | 5 | (24) |
T4 | 3 | (14) |
N-category | ||
N0 | 1 | (5) |
N1 | 5 | (24) |
N2 | 12 | (57) |
N3 | 3 | (14) |
Treatment | ||
Radiation alone | 4 | (19) |
Concurrent ChemoRadiation | 9 | (43) |
Induction Chemotherapy + Radiation | 1 | (5) |
Induction Chemotherapy + Concurrent ChemoRadiation | 7 | (33) |
Radiation dose | ||
Mean (SD) | 69.2 | (1.7) |
Radiation fractions | ||
Mean (SD) | 33 | (2) |